NICE approves novel oral migraine preventative drug

Draft NICE guidance has approved rimegepant, a novel oral drug for preventing migraine, which it said could become available to 145,000 NHS patients. Rimegepant is the first drug of its class to come in pill form, with other similar medications administered as injections. The calcitonin gene-related peptide (CGRP) receptor antagonist was also the first of... Read moreThe post NICE approves novel oral migraine preventative drug appeared first on Nursing in Practice.
Source: Nursing in Practice - Category: Nursing Authors: Tags: Clinical Source Type: news